Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huanyin Biotech is a specialized biotechnology company headquartered in Suzhou, China, focusing on the frontier of single-cell multi-omics and spatial transcriptomics. The company provides high-throughput sequencing services and bioinformatics analysis to help researchers and pharmaceutical companies decode cellular heterogeneity in complex diseases. Their core technology platform is designed to identify novel biomarkers and therapeutic targets, particularly within the fields of oncology, immunology, and neurology. By bridging the gap between basic research and clinical application, Huanyin Biotech aims to accelerate the development of precision therapies and diagnostic tools. The company's integrated approach combines advanced laboratory techniques with proprietary computational algorithms to deliver high-resolution insights into tissue microenvironments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huanyin.